Utah Medical Products (UTMD) Rating Increased to Buy at BidaskClub

Utah Medical Products (NASDAQ:UTMD) was upgraded by investment analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Wednesday.

Utah Medical Products (UTMD) opened at $89.65 on Wednesday. The stock has a market capitalization of $336.53, a P/E ratio of 39.15 and a beta of 0.77. Utah Medical Products has a one year low of $58.50 and a one year high of $94.00.

Utah Medical Products (NASDAQ:UTMD) last issued its earnings results on Tuesday, January 30th. The medical instruments supplier reported $0.95 earnings per share (EPS) for the quarter. The business had revenue of $10.20 million during the quarter. Utah Medical Products had a return on equity of 18.92% and a net margin of 20.54%.

Hedge funds have recently modified their holdings of the company. Acadian Asset Management LLC purchased a new position in shares of Utah Medical Products during the 4th quarter worth approximately $130,000. Acrospire Investment Management LLC raised its stake in shares of Utah Medical Products by 339.1% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,919 shares of the medical instruments supplier’s stock worth $139,000 after buying an additional 1,482 shares in the last quarter. SG Americas Securities LLC purchased a new position in shares of Utah Medical Products during the 4th quarter worth approximately $189,000. Strs Ohio raised its stake in shares of Utah Medical Products by 8.0% during the 2nd quarter. Strs Ohio now owns 2,700 shares of the medical instruments supplier’s stock worth $195,000 after buying an additional 200 shares in the last quarter. Finally, Everett Harris & Co. CA purchased a new position in shares of Utah Medical Products during the 2nd quarter worth approximately $210,000. 67.92% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “Utah Medical Products (UTMD) Rating Increased to Buy at BidaskClub” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/02/07/utah-medical-products-utmd-rating-increased-to-buy-at-bidaskclub-2.html.

About Utah Medical Products

Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply